NasdaqGS - Nasdaq Real Time Price • USD ICU Medical, Inc. (ICUI) Follow Compare 154.35 -6.64 (-4.12%) At close: January 10 at 4:00:02 PM EST 153.74 -0.61 (-0.40%) After hours: January 10 at 7:59:47 PM EST All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations ICU Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference SAN CLEMENTE, Calif., Jan. 03, 2025 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the 43rd Annual J.P. Morgan Healthcare Conference being held in San Francisco, California, January 13-16, 2025. ICU Medical’s presentation will be on Wednesday, January 15, 2025 at 10:30 a.m. PT (1:30 p.m. ET). Company management will also be participating in one-on-one meetings Calculating The Fair Value Of ICU Medical, Inc. (NASDAQ:ICUI) Key Insights The projected fair value for ICU Medical is US$172 based on 2 Stage Free Cash Flow to Equity With US$157... ICU Medical, Inc. (NASDAQ:ICUI) Just Reported And Analysts Have Been Lifting Their Price Targets Shareholders might have noticed that ICU Medical, Inc. ( NASDAQ:ICUI ) filed its third-quarter result this time last... ICU Medical Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags ICU Medical ( NASDAQ:ICUI ) Third Quarter 2024 Results Key Financial Results Revenue: US$589.1m (up 6.5% from 3Q 2023... ICU Medical Inc (ICUI) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... ICU Medical Inc (ICUI) reports robust financial performance with a 7% revenue increase and raises full-year guidance, while unveiling a strategic partnership with Otsuka Pharmaceutical. ICU Medical (ICUI) Tops Q3 Earnings and Revenue Estimates ICU Medical (ICUI) delivered earnings and revenue surprises of 27.20% and 0.92%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock? ICU Medical: Q3 Earnings Snapshot ICUI) on Tuesday reported a loss of $33 million in its third quarter. The San Clemente, California-based company said it had a loss of $1.35 per share. Earnings, adjusted for amortization costs and pretax expenses, came to $1.59 per share. ICU Medical, Inc. and Otsuka Pharmaceutical Factory, Inc., a Subsidiary of Otsuka Holdings Co. Ltd., Announce Creation of a Joint Venture to Bolster IV Solutions Manufacturing and Innovation in North America ICU Medical, Inc. (NASDAQ:ICUI), a worldwide leader in the development, manufacture and sale of innovative medical devices, and Otsuka Pharmaceutical Factory, Inc. (OPF), global IV solutions manufacturing subsidiary of Otsuka Holdings Co., Ltd., together announce the creation of a joint venture to provide additional supply chain resiliency and innovation to the North American IV solutions market. ICU Medical Announces Third Quarter 2024 Results and Updates Its Fiscal Year 2024 Guidance SAN CLEMENTE, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended September 30, 2024. Third Quarter 2024 Results Third quarter 2024 revenue was $589.1 million, as compared to $553.3 million in the same period in the prior year. GAAP gross profit for the third quarter of 2024 was $204.9 million, as compared to $183.9 million in t ICU Medical to Participate at the UBS Global Healthcare Conference SAN CLEMENTE, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the UBS Global Healthcare Conference being held in Rancho Palos Verdes, California, November 11-14, 2024. ICU Medical’s presentation will be on Wednesday, November 13, 2024 at 4:15 p.m. PT (7:15 p.m. ET). Company management will also be participating in one-on-one meetings on We Earnings Preview: Capricor Therapeutics (CAPR) Q3 Earnings Expected to Decline Capricor (CAPR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. ICU Medical (ICUI) Expected to Beat Earnings Estimates: Should You Buy? ICU Medical (ICUI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. ICU Medical Announces Time of Third Quarter 2024 Earnings Conference Call SAN CLEMENTE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its third quarter 2024 earnings release and conference call. The Company will release its third quarter 2024 results on Tuesday, November 12th, 2024 at approximately 4:00 p.m. ET (1:00 p.m. PT) and will be conducting a conference call concerning those results at 4:30 p.m. ET (1:30 p.m. PT) on Tuesda Will ICU Medical (ICUI) Beat Estimates Again in Its Next Earnings Report? ICU Medical (ICUI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report. Smiths recalls ventilators over risk of oxygen flow disruption Smiths has grappled with multiple quality issues and recalls over the past few years. Two recent recalls focus on problems with portable ventilators. ICU Medical's Stock Rises Despite Bivona Tracheostomy Tube Recall ICUI's Smiths Medical recalls Bivona tracheostomy tubes over a defect that may lead to serious health risks, including airway loss and death. Rockwell Medical, Inc. (RMTI) Hits Fresh High: Is There Still Room to Run? Rockwell Medical (RMTI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues. Investors ignore increasing losses at ICU Medical (NASDAQ:ICUI) as stock jumps 4.1% this past week The simplest way to invest in stocks is to buy exchange traded funds. But one can do better than that by picking better... ICU Medical Recalls Certain Tracheostomy Tubes Due To Manufacturing Defects On Wednesday, ICU Medical Inc’s (NASDAQ:ICUI) subsidiary, Smiths Medical, initiated a recall of certain Bivona neonatal/pediatric and adult tracheostomy tubes. The FDA classified the recall as the most serious type, which could cause severe injury or death. Smiths Medical is recalling specific lots of Bivona Neonatal/Pediatric and Adult Tracheostomy tubes due to a manufacturing defect that may cause the securement flange of the device to tear. Affected products include: Bivona Aire-Cuf, TTS, Unc ICU Medical, Inc. (ICUI) Hits Fresh High: Is There Still Room to Run? ICU Medical (ICUI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues. Performance Overview Trailing total returns as of 1/10/2025, which may include dividends or other distributions. Benchmark is S&P 500 Return ICUI S&P 500 YTD +0.10% -1.35% 1-Year +60.83% +22.51% 3-Year -32.61% +24.59%